India To Continue Using Hydroxychloroquine To Battle COVID-19, Says ICMR
Is HCQ a miracle drug or a death pill? The country apex body in the field, Indian Council of Medical Research (ICMR), stated that India will continue to use the anti-malarial drug Hydroxychloroquine on infected patients to battle the COVID-19 pandemic. It has found that the consumption of the “miracle” drug reduces the probability of contracting the deadly virus. On Tuesday, May 26, the World Health Organisation (WHO) had slammed the drug and temporarily paused its clinical trials on patients.
The debate is indeed serious. One of the world’s oldest and best known medical journals, Lancet has published a new study. It says HCQ raises the risk of death. Despite the suspension of trials by WHO, India will continue to use the wonder drug. The ICMR has claimed that HCQ possesses anti-viral properties and its benefits outweigh its side effects. Meanwhile, it has also cautioned that the anti-viral drug must not be consumed on an empty stomach.
Get more news updates only on ZEE5.